Accueil | Fils de syndication
Afficher l'Article
LDL Cholesterol Level Predicts HCV Therapy Response in Patients With HIV Coinfection
Tiistai, Kesäkuu 24, 2008 - 07:57 - 6 kuukaudet, 2 viikot depuis - Presse spécialisée - Medscape HIV AIDS
Patients coinfected with hepatitis C virus (HCV) and HIV who have high pretreatment LDL cholesterol levels are more likely to respond to HCV therapy than are similar patients with low LDL cholesterol levels, according to a report in the May 11th issue of AIDS. Reuters Health Information
